TrimRX
US$ 24.98
health pharma news today obesity drugs glp-1 today Chart: 1 in 8 Americans Now Use for Weight Loss New Daily GLP-1 Weight Loss
Description
Triglycerides dropped
Safety Profile and Tolerability Concerns Gastrointestinal Adverse Effects While GLP-1RAs are effective in managing obesity, their use is associated with gastrointestinal side effects and rare but serious adverse events [42] [43] [44]
JAMA psychiatry , 82 (1), 9498
Perkovic, V
Additionally, in Scandinavian cohort studies, event rates of heart failure (HF), stroke, incident CKD and cardiorenal-related death were higher in type 1 diabetes than in type 2 diabetes [7]
Lastly, we present considerations to accurately interpret these data and outline key knowledge gaps for further investigation
